By: Dahlia Chavez.
For many people living with endometriosis, disability does not start and stop in the pelvis. It shows up in energy levels, brain fog, pain flares, gastrointestinal symptoms, missed classes, canceled plans, and a body that feels like it is constantly “overreacting.”
For decades, medicine has treated endometriosis as a localized gynecologic condition. Lesions were the focus. Hormones were the solution. Experiences that didn’t fit that framework were often reframed as stress, anxiety, or something unrelated altogether.
A common counterargument is that endometriosis appears localized because lesions are visible and many patients improve after surgery or hormonal suppression. That improvement is real and meaningful. However, this framing does not explain why so many patients continue to experience whole-body symptoms, recurrence, and inflammation that extends beyond the pelvis.
The science supports a different narrative.
As someone living with endometriosis, training in medicine, and working in disability advocacy, the recent research feels validating for a simple reason: it explains why endometriosis affects the whole body, not just one organ system.
One of the most essential immune players in endometriosis research right now is the T-regulatory cells, or T-regs. You can think of T-regs as the immune system’s brakes.
Your immune system responds to threats such as viruses, bacteria, and injury. Once the immune system clears the threat, regulatory cells signal it to shut down the inflammatory response. That’s the job of T-regs. They prevent inflammation from spiraling out of control, stop the immune system from attacking the body itself, and help the body return to baseline after stress or illness.
In people with endometriosis, multiple studies show that T-regs do not function normally. They may be fewer in number, less effective, or misdirected. T-regs then lead to inflammation continuing without anything to shut it down, thereby supporting the presence and growth of endometriosis lesions.
When regulatory control fails, the immune system stays locked in a low-grade inflammatory state. This is where the science becomes very real for patients. If the immune “brakes” fail, even minor stressors can trigger exaggerated responses, much like what occurs in autoimmune conditions. The body continues to accelerate inflammatory activity rather than slow it down.
Therefore, for someone with endometriosis, a simple cold doesn’t just mean a runny nose and slight discomfort. It can trigger days or weeks of fatigue, pain flares, brain fog, GI upset, or worsening pelvic symptoms. The immune system revs up to fight the virus, but without strong T-reg control, it struggles to slow itself down after the virus is dealt with.
For a medical student or working professional with endometriosis, this might look like:
This is not a weakness. It is immune dysregulation.
Research shows that people with endometriosis often have an imbalance between T-regs and another immune cell type called Th17 cells, which are pro-inflammatory. If T-regs are the brakes, Th17 cells are the accelerator. When Th17 cells dominate, and T-regs cannot suppress them effectively, inflammation remains inappropriately activated. This inflammation can then spread beyond one organ system, further explaining why it’s often associated with whole-body symptoms like chronic fatigue, migraines, bowel dysfunction, and heightened pain sensitivity.
Endometriosis is not just a gynecologic condition. It is a systemic, immune-mediated disease with real implications for disability, stamina, cognition, and quality of life.
The immune system has been telling us this for years. Patients have too. Medicine is just finally starting to listen.
